We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$32.2B
AUM Growth
+$1.15B
Cap. Flow
+$886M
Cap. Flow %
2.75%
Top 10 Hldgs %
14.34%
Holding
3,060
New
26
Increased
2,469
Reduced
354
Closed
63

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$23.3M
2
XOM icon
ExxonMobil
XOM
+$22.8M
3
AAPL icon
Apple
AAPL
+$21.5M
4
WFC icon
Wells Fargo
WFC
+$19.8M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 14.4%
2 Financials 14.39%
3 Healthcare 13.67%
4 Industrials 10.84%
5 Consumer Discretionary 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBM icon
26
IBM
IBM
$204B
$208M 0.64%
1,434,713
+62,694
+5% +$8.01M
MRK icon
27
Merck
MRK
$323B
$203M 0.63%
4,013,178
+156,180
+4% +$7.65M
BAC icon
28
Bank of America
BAC
$436B
$202M 0.63%
14,931,921
+630,925
+4% +$8.52M
PM icon
29
Philip Morris
PM
$305B
$200M 0.62%
2,041,410
+80,645
+4% +$7.39M
ORCL icon
30
Oracle
ORCL
$345B
$198M 0.61%
4,832,694
+179,547
+4% +$6.65M
UNH icon
31
UnitedHealth
UNH
$379B
$192M 0.59%
1,485,722
+30,675
+2% +$3.63M
GILD icon
32
Gilead Sciences
GILD
$162B
$191M 0.59%
2,083,452
+15,940
+0.8% +$1.44M
MCD icon
33
McDonald's
MCD
$192B
$179M 0.56%
1,424,693
+12,735
+0.9% +$1.52M
C icon
34
Citigroup
C
$223B
$178M 0.55%
4,257,781
+206,714
+5% +$8.64M
AMGN icon
35
Amgen
AMGN
$203B
$177M 0.55%
1,183,354
+84,087
+8% +$12.5M
CVS icon
36
CVS Health
CVS
$137B
$176M 0.55%
1,700,394
+60,455
+4% +$5.88M
MMM icon
37
3M
MMM
$91.9B
$166M 0.52%
1,194,803
+17,043
+1% +$2.19M
MO icon
38
Altria Group
MO
$122B
$156M 0.49%
2,495,872
+153,688
+7% +$9.29M
WMT icon
39
Walmart Inc
WMT
$889B
$156M 0.48%
6,838,137
+262,428
+4% +$5.75M
MDT icon
40
Medtronic
MDT
$108B
$146M 0.45%
1,951,161
+132,955
+7% +$10M
BMY icon
41
Bristol-Myers Squibb
BMY
$128B
$144M 0.45%
2,259,978
+73,387
+3% +$4.63M
MA icon
42
Mastercard
MA
$487B
$141M 0.44%
1,490,281
+64,324
+5% +$5.69M
SLB icon
43
SLB Ltd
SLB
$76.5B
$136M 0.42%
1,849,658
+96,456
+6% +$6.78M
AGN
44
DELISTED
Allergan plc
AGN
$135M 0.42%
503,546
+27,432
+6% +$7.85M
SBUX icon
45
Starbucks
SBUX
$118B
$130M 0.4%
2,183,608
+59,202
+3% +$3.45M
ABBV icon
46
AbbVie
ABBV
$454B
$126M 0.39%
2,199,590
+71,052
+3% +$3.96M
NKE icon
47
Nike
NKE
$62.5B
$124M 0.38%
2,010,783
+60,647
+3% +$3.66M
HON icon
48
Honeywell
HON
$77.9B
$119M 0.37%
1,186,142
+30,003
+3% +$2.81M
QCOM icon
49
Qualcomm
QCOM
$179B
$119M 0.37%
2,324,067
+75,015
+3% +$3.66M
BA icon
50
Boeing
BA
$167B
$118M 0.37%
931,825
+19,869
+2% +$2.47M

Similar funds

RhumbLine Advisers's Q1 2016 Portfolio in Review

As of Q1 2016, RhumbLine Advisers held 3,060 positions worth $32.2B, up 3.7% from $31.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2016: portfolio turnover was 2.9%. RhumbLine Advisers opened 26 new positions and exited 63, leaving the 3,060-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2016 buy was Willis Towers Watson: 89,353 shares worth $10.6M.
  • RhumbLine Advisers added most to Broadcom in Q1 2016, an estimated $23.3M increase.
  • RhumbLine Advisers's biggest Q1 2016 reduction was Chubb, cutting an estimated $13.7M.
  • RhumbLine Advisers fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $43M.
  • RhumbLine Advisers's ten largest holdings make up 14% of its $32.2B portfolio in Q1 2016.
  • RhumbLine Advisers opened 26 new positions and closed 63 in Q1 2016.
  • RhumbLine Advisers's portfolio value rose 3.7% quarter-over-quarter to $32.2B.

Based on RhumbLine Advisers's 13F filing for Q1 2016, filed 2 May 2016.